In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.

Chennai: The implementation of Revised Schedule M guidelines for small and medium pharma companies by the end of this year will increase the capex requirements of the industry. This may also lead ...

Tailored for pharmaceutical and medical device professionals, this live seminar equips attendees with essential skills to conduct internal and vendor GMP audits in line with USFDA and ICH Q10 ...

Carbogen Amcis has been granted a GMP certificate for its 9,500m² Saint-Beauzire facility, supporting a wide range of ...

Assuring the quality of medicines requires a thorough understanding of pharmaceutical law and administration, Pharmaceutical Quality Systems (PQS) and Good Manufacturing Practice (GMP). Pharmaceutical ...

Stäubli Robotics has been active in the pharmaceutical industry for nearly two decades. It launched the world’s first six ... Eliminating contamination risks is the top priority in pharmaceutical ...

This initiative is part of the ministry’s broader strategy to reinforce Egypt’s pharmaceutical security while meeting ...

The launch of Denarase High Salt GMP-grade marks a significant milestone in c-LEcta’s commitment to providing innovative solutions for the biopharmaceutical industry. This engineered enzyme ...

Micro, small and medium enterprises (MSMEs) with revenue of less than ₹ 250 crore have to submit an application before the ...